Patrick Donnelly

Patrick Donnelly

Mr. Donnelly, who has more than 35 years of experience, was most recently Chairman and Chief Executive Officer of Aptiv Solutions, a global pharmaceutical development services business he founded which sold to ICON (NASDAQ:ICLR) in May 2014. Prior to this, Pat served as President, Chief Executive Officer, and was one of the founders of PRA International (now PRA Health Sciences, NASDAQ:PRAH). He was instrumental in building PRA over twelve years from a small regional contract research organization to a global leader in the industry. Mr. Donnelly received his M.B.A. from Pennsylvania State University in 1984 and received his BS from the University of Missouri in 1980.

Pat currently serves as a board director for Linden portfolio companies, ProPharma Group, and Advarra.  Pat is also a board director at MedGenesis Therapeutix, Phase 5 LLC, and Rediscovery Life Sciences.

Company Blog

November 29, 2018
Industry Poll: How Can Your GMP Auditing Program Be Most…
Expert insight into how you can take steps to best improve your GMP auditing… Read More
November 15, 2018
The Important Role of Advanced Therapy Medicinal Products
Today on the blog, a personal perspective from a colleague on the impact and… Read More
October 16, 2018
Outdated Facilities – Bring Back the ‘c’ in cGMP
Bringing the ‘c’ in the cGMP status back into your facility, processes, or procedures… Read More
More Articles

UPCOMING Events

January 28, 2019
DIA Pharmacovigilance and Risk Management Strategies Conference
Join us at DIA’s Pharmacovigilance and Risk Management Strategies Conference for context, background,... Read More
February 18, 2019
SCOPE – Summit for Clinical Ops Executives
SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-de... Read More
March 18, 2019
DIA Medical Affairs and Scientific Communications
DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, b... Read More
All Events
Contact Us